Antibodies to cyclooxygenase variants

Details Antibodies to cyclooxygenase variants Antibodies to cyclooxygenase variants

2006-11-17

2009-10-13

Gambel, Phillip (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S387100, C530S388100, C530S388260, C530S389100

Reexamination Certificate

active

07601816

ABSTRACT:
The invention relates to the isolation of novel cyclooxygenase type 1 (COX-1) variant enzymes. More specifically, the invention relates to the identification of cyclooxygenase transcripts harboring inton 1, or fragment thereof, of cyclooxygenase 1. The invention further relates to the diagnosis of aberrant cyclooxygenase type 1 variant gene or gene product; the identification, production, and use of compounds which modulate cyclooxygenase type 1 variant gene expression or the activity of the cyclooxygenase type 1 variant gene product including but not limited to nucleic acid encoding cyclooxygenase type 1 variants and homologues, analogues, and deletions thereof, as well as antisense, ribozyme, triple helix, antibody, and polypeptide molecules as well as small inorganic molecules; and pharmaceutical formulations and routes of administration for such compounds.

REFERENCES:
patent: 5543297 (1996-08-01), Cromlish et al.
patent: 5643960 (1997-07-01), Breitner et al.
patent: 6025395 (2000-02-01), Breitner et al.
patent: 6048850 (2000-04-01), Young et al.
patent: 6107087 (2000-08-01), O'Neill et al.
patent: 6187756 (2001-02-01), Lee et al.
patent: 6638744 (2003-10-01), Wisnewski et al.
patent: 2002/0064845 (2002-05-01), Wisnewski et al.
patent: 01228479 (1989-09-01), None
patent: 10324698 (1998-12-01), None
patent: WO 01/11026 (2001-02-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/90125 (2001-11-01), None
patent: WO 02/071928 (2002-09-01), None
Attwood Science 2000; 290:471-473.
Skolnick et al. Trends in Biotech. 2000; 18(1):34-39.
Lederman et al. Molecular Immunology 28: 1171-1181, 1991.
Li et al. PNAS 77: 3211-3214, 1980.
Ballou, et al. “Nociception in Cyclooxygenase Isozyme-Deficient Mice”,Proc. Natl. Acad. Sci., 97(18):10272-10276 (2000).
Botting, “Mechanism of Action of Acetaminophen: Is There A Cyclooxygenase 3?”,Clin, Infect. Dis., 31(Suppl. 5):S202-10 (2000).
Breitner, et al., “Delayed Onset of Alzheimer's Disease With Nonsteroidal Anti-inflammatory and Histamine H2 Blocking Drugs”,Neurobiology of Aging, 16(4):523-530 (1995).
DeWitt, et al., “PGH Synthase Isoenzyme Selectivity: The Potential for Safer Nonsteroidal Antiinflammatory Drugs”,Amer. J Med., 95(Suppl. 2A):40S-44S (1993).
Griffin, et al., “Brain Interleukin 1 and S-100 Immunoreactivity Are Elevated in Down Syndrome and Alzheimer Disease”,Proc. Natl. Acad. Sci., 88:7611-7615 (1989).
Herschmann et al., “TIS10, A Mitogen-inducible Glucocortiocoid-inhibited Gene That Encodes A Second Prostaglandin Synthase/Cyclooxygenase Enzyme”,J. Lipid Mediators, 6:89-99 (1993).
Hla & Neilson, “Human Cyclooxygenase-2 cDNA”,Proc. Natl. Acad. Sci., 89:7384-7388 (1992).
Jang, et al., “Cancer Chemopreventive Activity of Resveratrol, A Natural Product Derived From Grapes”,Science, 275:218-220 (1997).
Johnson, et al., “Complement mRNA In The Mammalian Brain: Responses to Alzheimer's Disease and Experimental Brain Lesioning”,Neurobiol. Aging, 13:641-648 (1992).
Lipsky, P.E. & Isakson, P.C., “Outcome of Specific COX-2 Inhibition in Rheumatoid Arthritis”,Journal of Rheumatol., 24(Suppl. 49):9-14 (1997).
Masferrer, et al., “Selective Inhibition of Inducible Cyclooxygenase 2 in vivo is Antiinflammatory and Nonulcerogenic”,Proc. Natl. Acad. Sci., 91:3228-3232 (1994).
McGeer, P.L. & Rogers, J., “Anti-inflammatory Agents As A Therapeutic Approach to Alzheimer's Disease”,Neurology, 42(2):447-449 (1992).
McGeer, P.L. & McGeer, E.G., “The Inflammatory System of Brain: Implications For Therapy of Alzheimer and Other Neurodegenerative Diseases”,Brain Res. Rev., 21(2):195-218 (1995).
McGeer, et al., “Anti-inflammatory Drugs and Alzheimer's Disease”,The Lancet, 335(8696):1037 (1990).
Schnabel, J., “New Alzheimer's Therapy Suggested”,Science260(515):1719-1720 (1993).
Simmons, et al., “Drug Inhibition and Cellular Regulation of Prostaglandin G/H Synthase Isoenzyme 2”,J. Lipid Mediators, 6:113-117(1993).
Vane, “Towards A Better Aspirin”,Nature, 367(6460):215 (1994).
Xie, et al., “Expression of A Mitogen-Responsive Gene Encoding Prostaglandin Synthase in Regulated by mRNA Splicing”,Proc. Natl. Acad. Sci., 88:2692-2696 (1991).
Yamagata, et al., “Expression of A Mitogen-inducible Cyclooxygenase in Brain Neurons: Regulation by Synaptic Activity and Glucocorticoids”,Neuron, 11(2):371-386 (1993).
Wang, L-H et al., “Characterization of the Promoter of Human Prostaglandin H Synthase-1 Gene”,Biochem Biophys. Res. Commun., 190:406-411(1993).
Treismann et al., EMBL Database Accession No. P1; T13049 (1999).
Vogiagis et al., “Cyclooxygenase-1 and An Alternatively Spliced mRNA in the Rat Stomach: Effects of Aging and Ulcers”,Am. J. Physiol. Gastrointest Liver Physiol., May 2000, vol. 278, No. 5, pp. G820-G827.
Funk et al., P2319, NCBI, 1991.
Takahashi Y et al., “Immunoaffinity Purification and cDNA Cloning of Human Platelet Prostaglandin Endoperoxide Synthase (Cyclooxygenase)”,Biochem. Biophys. Res. Commun., 182:433-438 (1992).
EBI Accession No. EM—PAT: AX082876, EMBL Database, Feb. 28, 2001, “Sequence 5 from Patent WO0111026.”
EBI Accession No. EM—HUM: S78220, EMBL Database, Nov. 26, 1993, “prostaglandin endoperoxide synthase [human, platelets, mRNA, 1812 nt].”
EBI Accession No. EM—HUM: S36271, EMBL Database, Feb. 16, 1993, “prostaglandin G/H synthase [human, lung, fibroblast, mRNA, 2435 nt].”
EBI Accession No. UNIPROT: P18488, UniProt Database, Nov. 1, 1990, “Homeotic protein empty spiracles.”

Affiliated with

Also associated with

Rating

Antibodies to cyclooxygenase variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to cyclooxygenase variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to cyclooxygenase variants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4091287